GSK · LONDON STOCK EXCHANGE ·
GSK plc
Jemperli approved in MSI-H/dMMR rectal cancer
Our AI’s take
Today's FDA approval of Jemperli for MSI‑H/dMMR locally advanced rectal cancer marks a regulatory milestone for GSK, extending the drug’s label into a…
The full digestion is for members. What is good, what is bad and why, the numbers that matter, and the chart, then ask about it by voice or text.
Join freeNew to announcements? Learn what an RNS is and why prices move.